Biomarkers for Sepsis
Joint Authors
Losa, Juan
Henriquez-Camacho, Cesar
Source
Issue
Vol. 2014, Issue 2014 (31 Dec. 2014), pp.1-6, 6 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2014-03-30
Country of Publication
Egypt
No. of Pages
6
Main Subjects
Abstract EN
Bloodstream infections are a major concern because of high levels of antibiotic consumption and of the increasing prevalence of antimicrobial resistance.
Bacteraemia is identified in a small percentage of patients with signs and symptoms of sepsis.
Biomarkers are widely used in clinical practice and they are useful for monitoring the infectious process.
Procalcitonin (PCT) and C-reactive protein (CRP) have been most widely used, but even these have limited abilities to distinguish sepsis from other inflammatory conditions or to predict outcome.
PCT has been used to guide empirical antibacterial therapy in patients with respiratory infections and help to determine if antibacterial therapy can be stopped.
New biomarkers such as those in this review will discuss the major types of biomarkers of bloodstream infections/sepsis, including soluble triggering receptor expressed on myeloid cells-1 (sTREM-1), soluble urokinase-type plasminogen receptor (suPAR), proadrenomedullin (ProADM), and presepsin.
American Psychological Association (APA)
Henriquez-Camacho, Cesar& Losa, Juan. 2014. Biomarkers for Sepsis. BioMed Research International،Vol. 2014, no. 2014, pp.1-6.
https://search.emarefa.net/detail/BIM-480489
Modern Language Association (MLA)
Henriquez-Camacho, Cesar& Losa, Juan. Biomarkers for Sepsis. BioMed Research International No. 2014 (2014), pp.1-6.
https://search.emarefa.net/detail/BIM-480489
American Medical Association (AMA)
Henriquez-Camacho, Cesar& Losa, Juan. Biomarkers for Sepsis. BioMed Research International. 2014. Vol. 2014, no. 2014, pp.1-6.
https://search.emarefa.net/detail/BIM-480489
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-480489